Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors

ABSTRACT:

SUBMITTER: Cabel C 

PROVIDER: S-EPMC12142043 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature